首页> 外文期刊>Cancer letters >Determining tissue origin of circulating epithelial cells (CEC) in patients with differentiated thyroid cancer by real-time PCR using thyroid mRNA probes
【24h】

Determining tissue origin of circulating epithelial cells (CEC) in patients with differentiated thyroid cancer by real-time PCR using thyroid mRNA probes

机译:使用甲状腺mRNA探针使用实时PCR测定分化甲状腺癌患者循环上皮细胞(CEC)的组织来源

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study is to determine whether circulating epithelial cells (CEC) detected in patients with differentiated thyroid cancer (DTC) stem from the thyroid gland. CEC have been described to increase in patients with progressive cancer disease and thus have been used as a marker of tumour cell dissemination. CEC were selected from venous blood samples of five DTC patients and analysis of thyroid-specific mRNA (i.e. Tg, TSH-R, TPO, NIS) was performed on a single cell level. 16/48 cells were positive for at least three different thyroid-mRNA transcripts, predominantly found in patients with detectable serum thyroglobulin. In conclusion, evidence was found that in patients with detectable serum thyroglobulin, most of the CECs originate from the thyroid gland. However, further investigations including a larger sample size are needed to validate the clinical impact of this method. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
机译:本研究的目的是确定在分化的甲状腺癌(DTC)患者中检测到循环上皮细胞(CEC)是否源自甲状腺。 已描述CEC以增加患有癌症疾病的患者,因此已被用作肿瘤细胞传播的标志物。 CEC从五个DTC患者的静脉血液样本中选择,并在单细胞水平上进行甲状腺特异性mRNA(即TG,TSH-R,TPO,NIS)分析。 16/48细胞对于至少三种不同的甲状腺-mRNA转录物阳性,主要发现可检测血清甲状腺素蛋白的患者。 总之,发现证据表明,在可检测血清甲状腺素蛋白的患者中,大多数CEC来自甲状腺。 然而,需要进一步调查,包括较大的样本量来验证该方法的临床影响。 (c)2014年Elsevier Ireland Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号